A phase I pharmacokinetics study comparing PF-06439535 (a potential biosimilar) with bevacizumab in healthy male volunteers
Crossref DOI link: https://doi.org/10.1007/s00280-016-3001-2
Published Online: 2016-03-16
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Knight, Beverly
Rassam, Danielle
Liao, Shanmei
Ewesuedo, Reginald
Funding for this research was provided by:
Pfizer
License valid from 2016-03-16